Paper38869737
Synthesis, molecular docking and molecular dynamics simulations, drug-likeness studies, ADMET prediction and biological evaluation of novel pyrazole-carboxamides bearing sulfonamide moiety as potent carbonic anhydrase inhibitors.
Yetek İ and 4 others. Mol Divers, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Synthesis, molecular docking and molecular dynamics simulations, drug-likeness studies, ADMET prediction and biological evaluation of novel pyrazole-carboxamides bearing sulfonamide moiety as potent carbonic anhydrase inhibitors. Papers, record 38869737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38869737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Synthesis, molecular docking and molecular dynamics simulations, drug-likeness studies, ADMET prediction and biological evaluation of novel pyrazole-carboxamides bearing sulfonamide moiety as potent carbonic anhydrase inhibitors.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbonic Anhydrase Inhibitors | Major topic |
| Molecular Docking Simulation | Major topic |
| Pyrazoles | Major topic |
| Molecular Dynamics Simulation | Major topic |
| Sulfonamides | Major topic |
| Humans | |
| Carbonic Anhydrase II | |
| Structure-Activity Relationship | |
| Carbonic Anhydrase I | |
| Molecular Structure |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022-02 | Kütahya Dumlupınar University Scientific Research Projects Coordination Office | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18336311 | Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? | Curr Pharm Des | 2008 | https://conductscience.org/library/papers/18336311 | PubMed |
| 2 | 23218470 | Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes. | Bioorg Med Chem | 2013 | https://conductscience.org/library/papers/23218470 | PubMed |
| 3 | 18952442 | Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents. | Bioorg Med Chem | 2008 | https://conductscience.org/library/papers/18952442 | PubMed |
| 4 | 24681068 | Synthesis, structure-activity relationships, and in vitro antibacterial and antifungal activity evaluations of novel pyrazole carboxylic and dicarboxylic acid derivatives. | Eur J Med Chem | 2014 | https://conductscience.org/library/papers/24681068 | PubMed |
| 5 | 19211803 | Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19211803 | PubMed |
| 6 | 4964830 | Esterase activities of human carbonic anhydrases B and C. | J Biol Chem | 1967 | https://conductscience.org/library/papers/4964830 | PubMed |
| 7 | 34474201 | Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones. | Comput Biol Chem | 2021 | https://conductscience.org/library/papers/34474201 | PubMed |
| 8 | 19444816 | CHARMM: the biomolecular simulation program. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19444816 | PubMed |
| 9 | 19362844 | Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes. | Bioorg Med Chem | 2009 | https://conductscience.org/library/papers/19362844 | PubMed |
| 10 | 14165909 | CARBONIC ANHYDRASES FROM HUMAN ERYTHROCYTES. PREPARATION AND PROPERTIES OF TWO ENZYMES. | J Biol Chem | 1964 | https://conductscience.org/library/papers/14165909 | PubMed |
| 11 | 16395289 | Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. | J Cereb Blood Flow Metab | 2006 | https://conductscience.org/library/papers/16395289 | PubMed |
| 12 | 12676895 | Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. | J Med Genet | 2003 | https://conductscience.org/library/papers/12676895 | PubMed |
| 13 | 20724038 | Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/20724038 | PubMed |
| 14 | 17228881 | Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. | J Med Chem | 2007 | https://conductscience.org/library/papers/17228881 | PubMed |
| 15 | 19703035 | Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? | Chem Biol Drug Des | 2009 | https://conductscience.org/library/papers/19703035 | PubMed |
| 16 | 5432063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 17 | 29232583 | Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage. | Eur J Med Chem | 2018 | https://conductscience.org/library/papers/29232583 | PubMed |
| 18 | 8795459 | Membrane carbonic anhydrase (IV) and ciliary epithelium. Carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. | Exp Eye Res | 1996 | https://conductscience.org/library/papers/8795459 | PubMed |
| 19 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 20 | 15028762 | Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells. | J Neurosci | 2004 | https://conductscience.org/library/papers/15028762 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42094731 | Toxicological investigation of mycotoxin contaminants and antibiotic residues associated with the poultry industry and their impact on human health. | RSC Adv | 2026 | https://conductscience.org/library/papers/42094731 | PubMed |
| 39534850 | Exploring heterocyclic scaffolds in carbonic anhydrase inhibition: a decade of structural and therapeutic insights. | RSC Adv | 2024 | https://conductscience.org/library/papers/39534850 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP24A1 | 1591 | PubTator's text mining | https://conductscience.org/library/genes/1591 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38869737
GET https://conductscience.org/api/papers/v1/38869737/references?page=2